초록 ▼

A stabilized hemoglobin solution is contacted with polymerizing agent. The stabilized hemoglobin solution includes stabilized tetrameric hemoglobin. At least a portion of the stabilized tetrameric hemoglobin is polymerized by reaction with the polymerizing agent, thereby producing a polymerized hemo

A stabilized hemoglobin solution is contacted with polymerizing agent. The stabilized hemoglobin solution includes stabilized tetrameric hemoglobin. At least a portion of the stabilized tetrameric hemoglobin is polymerized by reaction with the polymerizing agent, thereby producing a polymerized hemoglobin solution. In one embodiment, the stabilized hemoglobin solution includes a filtrate formed by filtrating polymerized solution of native hemoglobin through a filter having a molecular weight cut off of about 100 kD.

대표청구항 ▼

What is claimed is: 1. A method for forming a polymerized hemoglobin solution from a stabilized hemoglobin solution, wherein, the stabilized hemoglobin solution includes hemoglobin that has previously been exposed to glutaraldehyde and then subsequently to a reducing agent, comprising the step of:

What is claimed is: 1. A method for forming a polymerized hemoglobin solution from a stabilized hemoglobin solution, wherein, the stabilized hemoglobin solution includes hemoglobin that has previously been exposed to glutaraldehyde and then subsequently to a reducing agent, comprising the step of: exposing the stabilized hemoglobin solution to glutaraldehyde to further polymerize at least a portion of the hemoglobin present in the stabilized hemoglobin solution, whereby the average molecular weight of the stabilized hemoglobin solution increases to thereby produce the polymerized hemoglobin solution. 2. A method of claim 1, wherein the stabilized hemoglobin is present in a physiological buffer when contacted with glutaraldehyde. 3. A method of claim 2, wherein the physiological buffer has a pH of about 7.6 to about 7.9. 4. A method of claim 2, wherein the physiological buffer includes at least one component selected from the group consisting of: sodium lactate, N-acetyl-L-cysteine, sodium chloride, potassium chloride, and calcium chloride.2H2O. 5. A method of claim 3, wherein the physiological buffer includes sodium lactate at a concentration of about 290 to about 330 mg/100 ml. 6. A method of claim 3, wherein the physiological buffer includes N-acetyl-L-cysteine at a concentration of about 130 to about 220 mg/100 ml. 7. A method of claim 3, wherein the physiological buffer includes sodium chloride at a concentration of about 570 to about 620 mg/100 ml. 8. A method of claim 3, wherein the physiological buffer includes potassium chloride at a concentration of about 27 to about 33 mg/100 ml. 9. A method of claim 3, wherein the physiological buffer includes calcium chloride.2H2O at a concentration of about 18 to about 22 mg/100 ml. 10. A method of claim 1, wherein the stabilized hemoglobin solution comprises bovine hemoglobin. 11. A method of claim 1, wherein the concentration of the hemoglobin in the stabilized hemoglobin solution during the further polymerization is about 40 grams per liter. 12. A method of claim 1, wherein the concentration of glutaraldehyde added to the stabilized hemoglobin solution is about 1 to about 20 grams of glutaraldehyde per kilogram of total hemoglobin present in the stabilized hemoglobin solution. 13. A method of claim 12, wherein the concentration of glutaraldehyde in the stabilized hemoglobin solution is about 10 grams of glutaraldehyde per kilogram of total hemoglobin present in the stabilized hemoglobin solution. 14. The method of claim 1, wherein no more than about 10% by weight of the hemoglobin present in the polymerized hemoglobin solution has a molecular weight of at least about 500 kD. 15. A method of claim 1, wherein between about 45% and about 65% by weight of total hemoglobin present in the polymerized hemoglobin solution is tetrameric and octameric hemoglobin. 16. A method of claim 1, wherein no more than about 40% by weight of total hemoglobin present in the polymerized hemoglobin solution has as molecular weight of about 65 kD or less. 17. A method of claim 1, wherein no more than 10% by weight of total hemoglobin present in the polymerized hemoglobin solution is methemoglobin. 18. The method of claim 1, further comprising directing the polymerized hemoglobin through a filter having a molecular weight cut off of at least about 100 kD, whereby the resulting retentate comprises a polymerized hemoglobin, wherein no more than about 15% by weight of the hemoglobin present in the retentate has a molecular weight of at least about 500 kD, and no more than about 10% by weight of the hemoglobin present in the retentate has a molecular weight of about 65 kD or less. 19. A method for forming a polymerized hemoglobin solution from a stabilized hemoglobin solution, wherein the stabilized hemoglobin solution includes hemoglobin that has previously been exposed to glutaraldehyde, and then subsequently to a reducing agent and a physiological buffer, comprising the step of: exposing the stabilized hemoglobin solution to glutaraldehyde at a concentration of about 1 to about 20 grams of glutaraldehyde per kilogram of hemoglobin present in the stabilized hemoglobin solution to further polymerize at least a portion of the hemoglobin present in the stabilized hemoglobin solution, whereby the average molecular weight of the stabilized hemoglobin solution increases to thereby produce the polymerized hemoglobin solution. 20. A method of claim 19, wherein the physiological buffer has a pH of about 7.6 to about 7.9. 21. A method of claim 19, wherein the physiological buffer includes at least one component selected from the group consisting of: sodium lactate, N-acetyl-L-cysteine, sodium chloride, potassium chloride, and calcium chloride.2H2O. 22. A method of claim 19, wherein the physiological buffer includes sodium lactate at a concentration of about 290 to about 330 mg/100 ml. 23. A method of claim 19, wherein the physiological buffer includes N-acetyl-L-cysteine at a concentration of about 130 to about 220 mg/100 ml. 24. A method of claim 19, wherein the physiological buffer includes sodium chloride at a concentration of about 570 to about 620 mg/100 ml. 25. A method of claim 19, wherein the physiological buffer includes potassium chloride at a concentration of about 27 to about 33 mg/100 ml. 26. A method of claim 19, wherein the physiological buffer includes calcium chloride.2H2O at a concentration of about 18 to about 22 mg/100 ml. 27. A method of claim 19, wherein the stabilized hemoglobin solution comprises bovine hemoglobin. 28. A method of claim 19, wherein the concentration of the hemoglobin in the stabilized hemoglobin solution during the further polymerization is about 40 grams per liter. 29. The method of claim 19, further includes the step of forming the stabilized hemoglobin solution. 30. A method of claim 19, wherein the concentration of glutaraldehyde added to the stabilized hemoglobin solution is about 10 grams of glutaraldehyde per kilogram of total hemoglobin present in the stabilized hemoglobin solution. 31. A method of claim 19, wherein no more than about 10% by weight of the hemoglobin present in the polymerized hemoglobin solution has a molecular weight of greater than about 500 kD. 32. A method of claim 19, wherein between about 45% and about 65% by weight of total hemoglobin present in the polymerized hemoglobin solution is tetrameric and octameric hemoglobin. 33. A method of claim 19, wherein no more than about 40% by weight of total hemoglobin present in the polymerized hemoglobin solution has a molecular weight of about 65 kDa or less. 34. The method of claim 19, wherein the stabilized hemoglobin has a pH of about 7.6 to about 7.9, and is a component of a solution that includes a) N-acetyl-L-cysteine at a concentration of about 130 to about 220 mg/100 ml b) sodium lactate at a concentration of about 290 to about 330 mg/100 ml: c) sodium chloride at a concentration of about 570 to about 620 mg/100 ml: d) potassium chloride at a concentration of about 18 to about 22 mg/100 ml; and e) calcium chloride.2H2O at a concentration of about 18 to about 22 mg/100 ml, and wherein the polymerized hemoglobin solution includes no more than about 10% by weight of total hemoglobin present in the hemoglobin solution has a molecular weight of at least about 500 kDa, no more than about 40% by weight of total hemoglobin has a molecular weight of about 65 kD or less, and no more than about 10% by weight of total hemoglobin is methemoglobin. 35. A method of claim 34, wherein the stabilized hemoglobin solution comprises bovine hemoglobin. 36. A method of claim 34, wherein the concentration of the hemoglobin in the stabilized hemoglobin solution during the further polymerization is about 40 grams per liter. 37. The method of claim 34, further including the step of directing the stabilized hemoglobin solution through a filter having a molecular weight cut off of at least about 100 kD, to thereby form a retentate of the polymerized hemoglobin solution, wherein no more than about 15% by weight of the hemoglobin present in the retentate has a molecular weight of at least about 500 kD, and no more than about 10% by weight of the hemoglobin present in the retentate has a molecular weight of about 65 kD or less. 38. A method for forming a polymerized hemoglobin solution from a stabilized hemoglobin solution, comprising the steps of: a) exposing a solution containing native hemoglobin to glutaraldhyde to form a hemoglobin solution containing polymerized hemoglobin; b) exposing the hemoglobin solution that contains polymerized hemoglobin to a reducing agent to form a stabilized hemoglobin solution; and c) further exposing the stabilized hemoglobin solution to glutaraldehyde to further polymerize at least a portion of the hemoglobin present in the stabilized hemoglobin solution, whereby the average molecular weight of the stabilized hemoglobin solution increases to thereby produce the polymerized hemoglobin solution. 39. The method of claim 38, further including the step of adding sodium borohydride to the further polymerized hemoglobin solution to thereby form said polymerized hemoglobin solution. 40. The method of claim 38, wherein the reducing agent is sodium borohydride. 41. The method of claim 1, further including the step of adding sodium borohydride to the further polymerized hemoglobin solution to thereby form said polymerized hemoglobin solution.